Lv1
30 积分 2025-07-18 加入
Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies
5小时前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
2个月前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
3个月前
已完结